Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabina Signoretti

Showing results (101-110 of 257) with videos related to

Pageof 26
Sort By:
European Urology|April 18, 2017
Evolution of Circulating Tumor DNA Profile from First-line to Subsequent Therapy in Metastatic Renal Cell CarcinomaSumanta K Pal, Guru Sonpavde, Neeraj Agarwal, et al.
Clinical Genitourinary Cancer|May 15, 2018
Comprehensive Genomic Profiling of Metastatic Tumors in a Phase 2 Biomarker Study of Everolimus in Advanced Renal Cell CarcinomaXin Gao, Opeyemi Jegede, Connor Gray, et al.
BMC Cancer|September 16, 2021
Correction to: Outcomes based on plasma biomarkers in METEOR, a randomized phase 3 trial of cabozantinib vs everolimus in advanced renal cell carcinomaThomas Powles, Toni K Choueiri, Robert J Motzer, et al.
European Urology|June 26, 2012
BRAF mutations in metanephric adenoma of the kidneyToni K Choueiri, John Cheville, Emanuele Palescandolo, et al.
Cancer Research|August 1, 2024
Editor's Note: Androgen-Induced Differentiation and Tumorigenicity of Human Prostate Epithelial CellsRaanan Berger, Phillip G Febbo, Pradip K Majumder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2013
The role of aberrant VHL/HIF pathway elements in predicting clinical outcome to pazopanib therapy in patients with metastatic clear-cell renal cell carcinomaToni K Choueiri, André P Fay, Robert Gagnon, et al.
Cancer Research|December 18, 2004
Androgen-induced differentiation and tumorigenicity of human prostate epithelial cellsRaanan Berger, Phillip G Febbo, Pradip K Majumder, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 12, 2005
Modulation of epithelial neoplasia and lymphoid hyperplasia in PTEN+/- mice by the p85 regulatory subunits of phosphoinositide 3-kinaseJi Luo, Cassandra L Sobkiw, Nicole M Logsdon, et al.
European Urology Focus|July 21, 2017
Pharmacogenomic Markers of Targeted Therapy Toxicity in Patients with Metastatic Renal Cell CarcinomaGuillermo de Velasco, Kathryn P Gray, Lana Hamieh, et al.
Cancer Research|April 24, 2013
Animal models of human prostate cancer: the consensus report of the New York meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology CommitteeMichael Ittmann, Jiaoti Huang, Enrico Radaelli, et al.
Pageof 26

Showing results (101-110 of 257) with videos related to

Sort By:
Pageof 26
European Urology|April 18, 2017
Evolution of Circulating Tumor DNA Profile from First-line to Subsequent Therapy in Metastatic Renal Cell CarcinomaSumanta K Pal, Guru Sonpavde, Neeraj Agarwal, et al.
Clinical Genitourinary Cancer|May 15, 2018
Comprehensive Genomic Profiling of Metastatic Tumors in a Phase 2 Biomarker Study of Everolimus in Advanced Renal Cell CarcinomaXin Gao, Opeyemi Jegede, Connor Gray, et al.
BMC Cancer|September 16, 2021
Correction to: Outcomes based on plasma biomarkers in METEOR, a randomized phase 3 trial of cabozantinib vs everolimus in advanced renal cell carcinomaThomas Powles, Toni K Choueiri, Robert J Motzer, et al.
European Urology|June 26, 2012
BRAF mutations in metanephric adenoma of the kidneyToni K Choueiri, John Cheville, Emanuele Palescandolo, et al.
Cancer Research|August 1, 2024
Editor's Note: Androgen-Induced Differentiation and Tumorigenicity of Human Prostate Epithelial CellsRaanan Berger, Phillip G Febbo, Pradip K Majumder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2013
The role of aberrant VHL/HIF pathway elements in predicting clinical outcome to pazopanib therapy in patients with metastatic clear-cell renal cell carcinomaToni K Choueiri, André P Fay, Robert Gagnon, et al.
Cancer Research|December 18, 2004
Androgen-induced differentiation and tumorigenicity of human prostate epithelial cellsRaanan Berger, Phillip G Febbo, Pradip K Majumder, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 12, 2005
Modulation of epithelial neoplasia and lymphoid hyperplasia in PTEN+/- mice by the p85 regulatory subunits of phosphoinositide 3-kinaseJi Luo, Cassandra L Sobkiw, Nicole M Logsdon, et al.
European Urology Focus|July 21, 2017
Pharmacogenomic Markers of Targeted Therapy Toxicity in Patients with Metastatic Renal Cell CarcinomaGuillermo de Velasco, Kathryn P Gray, Lana Hamieh, et al.
Cancer Research|April 24, 2013
Animal models of human prostate cancer: the consensus report of the New York meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology CommitteeMichael Ittmann, Jiaoti Huang, Enrico Radaelli, et al.
Pageof 26